Intraoperative OCT Guidance of Intraocular Surgery II
Launched by DUKE UNIVERSITY · Oct 17, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Intraoperative OCT Guidance of Intraocular Surgery II," is exploring a new technology that helps doctors see detailed images of the eye during surgery. The goal is to improve how surgeries are performed for conditions like macular holes, retinal detachment, diabetic retinopathy, and cataracts, among others. By using this advanced imaging technology, the hope is to enhance surgical outcomes and make certain types of eye surgeries safer and more effective.
To participate in this study, you may be eligible if you are an adult (18 years or older) with healthy eyes or if you are scheduled for specific eye surgeries. Healthy participants can have minor vision issues, but those with serious eye diseases that could affect imaging are not eligible. Throughout the trial, participants can expect to undergo surgery with the added benefit of this new imaging technology, which aims to provide real-time information to the surgeons. This trial is currently recruiting participants of all genders, and it's an exciting opportunity to contribute to advancements in eye care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy controls: Healthy eyes without known disease: refractive error including myopia and non-significant cataract is allowed. For selected testing pseudophakia is allowed.
- • 2. Surgeons as research subjects: Adult (≥18 years old)
- • 3. Surgical patients (vitreoretinal surgery): Patients undergoing examination under anesthesia or surgery for vitreoretinal diseases
- • 4. Surgical patients (anterior segment surgery-glaucoma, ocular surface or strabismus requiring extraocular muscle surgery): Include both adults and children. Patient undergoing primary, elective minimally invasive glaucoma surgery, ocular surface surgery, or strabismus surgery.
- Exclusion Criteria:
- • 1. Healthy controls: Any ocular disease that restricts the ability to perform OCT scanning. Conflict of interest with investigators/study personnel, e.g. a student in the lab of an investigator.
- • 2. Surgeons as research subjects: no specific exclusion criteria.
- • 3. Surgical patients (vitreoretinal surgery): Neonates (\< 4 weeks of age) and patients with any ocular disease that restricts the ability to perform OCT scanning.
- • 4. Surgical patients (anterior segment surgery-corneal and cataract diseases): Pediatric patients: The cornea and cataract surgery studies will be restricted to adults (≥ 18 years). Children do not have cataract surgery typically by residents and therefore would not fit our study design. Similarly pediatric corneal transplants are very rare.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Cynthia A Toth, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials